Loading…
Reported covered position: Congressional Aide, 2003 - 2005
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Health Care Cost Reduction Act of 2012
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Generally supporting the delay and repeal of the medical device excise tax, including HR 436 and S 262.
Health Care Cost Reduction Act of 2012
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Generally supporting the repeal of the medical device excise tax, specifically HR 436 and S 262.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2012 · fourth_quarter · 4A
Generally supporting the delay and repeal of the medical device excise tax, including HR 436 and S 262.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2012 · fourth_quarter · Q4
Source: Senate LDA
Health Care Cost Reduction Act of 2012
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Generally supporting the delay and repeal of the medical device excise tax, including HR 436 and S 262.
Medicare Decisions Accountability Act of 2011
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Supporting the repeal of the Independent Payment Advisory Board (IPAB); specifically S 668 and HR 452.
Medicare Decisions Accountability Act of 2011
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Supporting the repeal of the Independent Payment Advisory Board (IPAB); specifically S 668 and HR 452.
Medicare Drug Savings Act of 2011
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Opposing the imposition of price controls in the Medicare program; specifically, HR 2190 as well as similar proposals offered to the Joint Select Committee on Deficit Reduction.
Generally supporting the delay and repeal of the medical device excise tax, including HR 436 and S 262.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2012 · third_quarter · Q3
Supporting the repeal of the Independent Payment Advisory Board (IPAB); specifically S 668 and HR 452.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2012 · second_quarter · Q2
Supporting the repeal of the Independent Payment Advisory Board (IPAB); specifically S 668 and HR 452.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2012 · first_quarter · Q1
Generally supporting the repeal of the medical device excise tax, specifically HR 436 and S 262.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2011 · fourth_quarter · Q4
Opposing the imposition of price controls in the Medicare program; specifically, HR 2190 as well as similar proposals offered to the Joint Select Committee on Deficit Reduction.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE